Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study: Precision Sedation in Intensive Care Using Neurophysiologic and Respiratory Targets.

NCT06991777 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT06991777
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06991777 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study: Precision Sedation in Intensive Care Using Neurophysiologic and Respiratory Targets.
Lead sponsor
Oslo University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
December 1, 2024
Completion date
May 31, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness